Avadel Pharmaceuticals plcAVDLNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Above historical average, modest growth trend.
Left:
||||
Price-to-book ratio
Latest
13.54
↑ 123% above average
Average (9y)
6.07
Historical baseline
Range
High:34.64
Low:-20.35
CAGR
+7.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 13.54 | +4.9% |
| 2023 | 12.90 | +163.4% |
| 2022 | -20.35 | -436.6% |
| 2021 | 6.04 | +177.1% |
| 2020 | 2.18 | +122.6% |
| 2019 | -9.67 | -127.9% |
| 2018 | 34.64 | +782.8% |
| 2017 | 3.92 | -61.5% |
| 2016 | 10.19 | +39.5% |
| 2015 | 7.30 | - |